View of QBD-DRIVEN DEVELOPMENT OF HYALURONIC ACID-CHITOSAN SURFACE-FUNCTIONALIZED NANOSTRUCTURED LIPID CARRIERS FOR TARGETED DELIVERY OF RESVERATROL IN NON-SMALL CELL LUNG CANCER

Return to Article Details QBD-DRIVEN DEVELOPMENT OF HYALURONIC ACID-CHITOSAN SURFACE-FUNCTIONALIZED NANOSTRUCTURED LIPID CARRIERS FOR TARGETED DELIVERY OF RESVERATROL IN NON-SMALL CELL LUNG CANCER Download Download PDF